semaglutide and small bowel obstruction GLP-1 Receptor Agonists in Diabetes Obesity: A Case Report and Review of Risks and Management Food-induced small bowel obstruction observed
Description
This meta-analysis suggests that GLP-1 RA reduce kidney disease progression in T2D or overweight/obesity regardless of CKD status
Obesity is a chronic disease associated with many complications
A major shift is coming to the global weight loss marketand it starts in China
Learn more about the benefits of Eli Lilly's new weight loss medication Orforglipron and see how it has faired in its clinical trials so far.
CBS News medical correspondent Dr
